|
CASC4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.593620E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.980300E-03 |
| Normal-vs-Stage2 |
1.378430E-01 |
| Normal-vs-Stage3 |
1.072820E-01 |
| Normal-vs-Stage4 |
2.254600E-01 |
| Stage1-vs-Stage2 |
9.106000E-01 |
| Stage1-vs-Stage3 |
9.955000E-01 |
| Stage1-vs-Stage4 |
7.620200E-01 |
| Stage2-vs-Stage3 |
9.111800E-01 |
| Stage2-vs-Stage4 |
6.969000E-01 |
| Stage3-vs-Stage4 |
7.730800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.362780E-03 |
| Normal-vs-AfricanAmerican |
4.096100E-03 |
| Normal-vs-Asian |
7.884200E-01 |
| Caucasian-vs-AfricanAmerican |
6.157800E-01 |
| Caucasian-vs-Asian |
3.444400E-01 |
| AfricanAmerican-vs-Asian |
2.155400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.118700E-03 |
| Normal-vs-Female |
2.848500E-04 |
| Male-vs-Female |
6.038000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.533900E-02 |
| Normal-vs-Extreme_Weight |
3.887700E-02 |
| Normal-vs-Obese |
6.295600E-03 |
| Normal-vs-Extreme_Obese |
6.951800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.674600E-01 |
| Normal_Weight-vs-Obese |
4.948000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.154800E-01 |
| Extreme_Weight-vs-Obese |
4.759000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.228800E-01 |
| Obese-vs-Extreme_Obese |
3.811800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.941370E-01 |
| Normal-vs-Age(41-60Yrs) |
4.65930000004278E-06 |
| Normal-vs-Age(61-80Yrs) |
8.606400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.246800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.990100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.496000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.322200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.797900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.494000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.717800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.78050000000574E-05 |
| Normal-VS-Type2 PRCC |
3.916400E-01 |
| Normal-VS-KIRP CIMP |
3.609800E-01 |
| Normal-VS-Unclassified PRCC |
1.913520E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.565650E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.292400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.305400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.349400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.129900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.039200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.329800E-01 |
| Normal-vs-N1 |
1.816800E-01 |
| Normal-vs-N2 |
5.538200E-01 |
| N0-vs-N1 |
2.644600E-01 |
| N0-vs-N2 |
4.500000E-01 |
| N1-vs-N2 |
8.951800E-01 |
|
|
